Absolute quantification of cell-bound DNA aptamers during SELEX

Nucleic Acid Therapeutics

Volumn 23, Issue 2, 2013, Pages 125-130

  Avci Adali, Meltem ^a   Wilhelm, Nadja ^a   Perle, Nadja ^a   Stoll, Heidi ^a   Schlensak, Christian ^a   Wendel, Hans P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; OLIGONUCLEOTIDE; SINGLE STRANDED DNA;

ARTICLE; CELL COMPONENT; CELL LYSATE; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; DNA DENATURATION; FLOW CYTOMETRY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IN VITRO SELECTION; IN VITRO STUDY; LIGAND BINDING; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

APTAMERS, NUCLEOTIDE; COMBINATORIAL CHEMISTRY TECHNIQUES; FLOW CYTOMETRY; HEK293 CELLS; HUMANS; LIGANDS; NUCLEIC ACIDS; OLIGONUCLEOTIDES; ORGANIC CHEMICALS; REAL-TIME POLYMERASE CHAIN REACTION; SELEX APTAMER TECHNIQUE;

EID: 84876215785     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2012.0406     Document Type: Article

References (22)

1. BOLTZ, A., PIATER, B., TOLEIKIS, L., GUENTHER, R., KOLMAR, H., and HOCK, B. (2011). Bi-specific aptamers mediating tumor cell lysis. J. Biol. Chem. 286, 21896-21905.
2. ELLINGTON, A.D., and SZOSTAK, J.W. (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822.
3. ESTEVEZ, M.C., HUANG, Y.F., KANG, H., et al. (2010). Nanoparticle-aptamer conjugates for cancer cell targeting and detection. Methods Mol. Biol. 624, 235-248.
4. GEIGER, A., BURGSTALLER, P., VON DER, E.H., ROEDER, A., and FAMULOK, M. (1996). RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity. Nucleic Acids Res. 24, 1029-1036.
5. GUO, K.T., SCHAFER, R., PAUL, A., GERBER, A., ZIEMER, G., and WENDEL, H.P. (2006). A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers. Stem Cells 24, 2220-2231.
6. GUO, K.T., ZIEMER, G., PAUL, A., and WENDEL, H.P. (2008). CELL-SELEX: Novel perspectives of aptamer-based therapeutics. Int. J. Mol. Sci. 9, 668-678.
7. HERR, J.K., SMITH, J.E., MEDLEY, C.D., SHANGGUAN, D., and TAN, W. (2006). Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. Anal. Chem. 78, 2918-2924.
8. HOFFMANN, J., PAUL, A., HARWARDT, M., et al. (2008). Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells. J. Biomed. Mater. Res. A 84, 614-621.
9. HUANG, Y.F., SHANGGUAN, D., LIU, H., et al. (2009). Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem. 10, 862-868.
10. LI, N., NGUYEN, H.H., BYROM, M., and ELLINGTON, A.D. (2011). Inhibition of cell proliferation by an anti-EGFR aptamer. PLoS One 6, e20299.
11. LIU, Z., DUAN, J.H., SONG, Y.M., et al. (2012). Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro. J. Transl. Med. 10, 148.
12. MAYER, G., AHMED, M.S., DOLF, A., ENDL, E., KNOLLE, P.A., and FAMULOK, M. (2010). Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures. Nat. Protoc. 5, 1993-2004.
13. MUSHEEV, M.U., and KRYLOV, S.N. (2006). Selection of aptamers by systematic evolution of ligands by exponential enrichment: addressing the polymerase chain reaction issue. Anal. Chim. Acta 564, 91-96.
14. NG, E.W., SHIMA, D.T., CALIAS, P., CUNNINGHAM, E.T., JR., GUYER, D.R., and ADAMIS, A.P. (2006). Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discov. 5, 123-132.
15. SANTULLI-MAROTTO, S., NAIR, S.K., RUSCONI, C., SULLENGER, B., and GILBOA, E. (2003). Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity. Cancer Res. 63, 7483-7489.
16. SCHÄ FER, R., WISKIRCHEN, J., GUO, K., et al. (2007). Aptamerbased isolation and subsequent imaging of mesenchymal stem cells in ischemic myocard by magnetic resonance imaging. Rofo 179, 1009-1015.
17. SEFAH, K., SHANGGUAN, D., XIONG, X., O'DONOGHUE, M.B., and TAN, W. (2010). Development of DNA aptamers using Cell-SELEX. Nat. Protoc. 5, 1169-1185.
18. SHI, H., HE, X., WANG, K., et al. (2011). Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration. Proc. Natl. Acad. Sci. U. S. A. 108, 3900-3905.
19. SONG, K.M., JEONG, E., JEON, W., CHO, M., and BAN, C. (2012). Aptasensor for ampicillin using gold nanoparticle based dual fluorescence-colorimetric methods. Anal. Bioanal. Chem. 402, 2153-2161.
20. TAKAHASHI, T., TADA, K., and MIHARA, H. (2009). RNA aptamers selected against amyloid beta-peptide (Abeta) inhibit the aggregation of Abeta. Mol. Biosyst. 5, 986-991.
21. TANG, Z., SHANGGUAN, D., WANG, K., et al. (2007). Selection of aptamers for molecular recognition and characterization of cancer cells. Anal. Chem. 79, 4900-4907.
22. TUERK, C., and GOLD, L. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510.